About BIOQUAL, INC.
BIOQUAL provides comprehensive in vivo and in vitro preclinical research services to both commercial and government clients, specializing in infectious diseases, immunogenicity, and oncology. The company has been in operation since 1981 and is committed to ethical animal treatment and scientific innovation.
In vivo and in vitro preclinical research servicesSmall and large animal models, including non-human primates (NHPs)Cell-based assays for proliferation, viability, apoptosis, viral load, and immunogenicity testingHigh-throughput screening for compound profilingImmunoassays such as ELISA, ELISpot, Luminex, Western blot, and flow cytometryToxicology testing and custom assay developmentBSL3 facilities for high-risk pathogen researchImaging services for mechanisms of action and therapeutic efficacy analysis
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Health and Human Services | $10K | |
| Federal contract award | Department of Health and Human Services | $15K | |
| Federal contract award | Department of Health and Human Services | $61K | |
| NIDDK: SEVERABLE - ACQUISITION OF SERVICES FOR HUMANIZED MICE STUDIES | Department of Health and Human Services | $195K | |
| Federal contract award | Department of Health and Human Services | $105K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to BIOQUAL, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.